The activity of 5-LO (5-lipoxygenase), which catalyses two initial steps in the biosynthesis of pro-inflammatory LTs (leukotrienes), is strictly regulated. One recently discovered factor, CLP (coactosin-like protein), binds 5-LO and promotes LT formation. In the present paper we report that CLP also stabilizes 5-LO and prevents non-turnover inactivation of the enzyme in vitro. Mutagenesis of tryptophan residues in the 5-LO β-sandwich showed that 5-LO-Trp102 is essential for binding to CLP, and for CLP to support 5-LO activity. In addition, the stabilizing effect also depended on binding between CLP and 5-LO. After mutations which prevent interaction (5-LO-W102A or CLP-K131A), the protective effect of CLP was absent. A calculated 5-LO–CLP docking model indicates that CLP may bind to additional residues in both domains of 5-LO, thus possibly stabilizing the 5-LO structure. To obtain further support for binding between CLP and 5-LO in a living cell, subcellular localization of CLP and 5-LO in the monocytic cell line Mono Mac 6 was determined. In these cells, 5-LO associates with a nuclear fraction only when differentiated cells are primed with phorbol ester and stimulated with ionophore. The same pattern of redistribution was found for CLP, indicating that the two proteins associate with the nucleus in a co-ordinated fashion. The results of the present study support a role for CLP as a chaperoning scaffold factor, influencing both the stability and the activity of 5-LO.
Skip Nav Destination
Article navigation
January 2010
-
Cover Image
Cover Image
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
Research Article|
December 14 2009
Coactosin-like protein functions as a stabilizing chaperone for 5-lipoxygenase: role of tryptophan 102
Julia Esser;
Julia Esser
1
*Department of Medical Biochemistry and Biophysics, Division of Physiological Chemistry II, Karolinska Institutet, S-171 77 Stockholm, Sweden
Search for other works by this author on:
Marija Rakonjac;
Marija Rakonjac
1
*Department of Medical Biochemistry and Biophysics, Division of Physiological Chemistry II, Karolinska Institutet, S-171 77 Stockholm, Sweden
Search for other works by this author on:
Bettina Hofmann;
Bettina Hofmann
†Institute of Pharmaceutical Chemistry/ZAFES, University of Frankfurt, Max-von-Laue-Str. 9, D-60438 Frankfurt am Main, Germany
‡Institute of Organic Chemistry and Chemical Biology, Johann Wolfgang Goethe-University, Siesmayerstr. 70, D-60323 Frankfurt am Main, Germany
Search for other works by this author on:
Lutz Fischer;
Lutz Fischer
*Department of Medical Biochemistry and Biophysics, Division of Physiological Chemistry II, Karolinska Institutet, S-171 77 Stockholm, Sweden
†Institute of Pharmaceutical Chemistry/ZAFES, University of Frankfurt, Max-von-Laue-Str. 9, D-60438 Frankfurt am Main, Germany
Search for other works by this author on:
Patrick Provost;
Patrick Provost
§CHUL Research Center/CHUQ and Faculty of Medicine, Université Laval, Quebec, QC, G1V 4G2, Canada
Search for other works by this author on:
Gisbert Schneider;
Gisbert Schneider
‡Institute of Organic Chemistry and Chemical Biology, Johann Wolfgang Goethe-University, Siesmayerstr. 70, D-60323 Frankfurt am Main, Germany
Search for other works by this author on:
Dieter Steinhilber;
Dieter Steinhilber
†Institute of Pharmaceutical Chemistry/ZAFES, University of Frankfurt, Max-von-Laue-Str. 9, D-60438 Frankfurt am Main, Germany
Search for other works by this author on:
Bengt Samuelsson;
Bengt Samuelsson
*Department of Medical Biochemistry and Biophysics, Division of Physiological Chemistry II, Karolinska Institutet, S-171 77 Stockholm, Sweden
Search for other works by this author on:
Olof Rådmark
Olof Rådmark
2
*Department of Medical Biochemistry and Biophysics, Division of Physiological Chemistry II, Karolinska Institutet, S-171 77 Stockholm, Sweden
2To whom correspondence should be addressed (email olof.radmark@ki.se).
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
June 05 2009
Revision Received:
September 24 2009
Accepted:
October 06 2009
Accepted Manuscript online:
October 06 2009
Online ISSN: 1470-8728
Print ISSN: 0264-6021
© The Authors Journal compilation © 2010 Biochemical Society
2010
Biochem J (2010) 425 (1): 265–274.
Article history
Received:
June 05 2009
Revision Received:
September 24 2009
Accepted:
October 06 2009
Accepted Manuscript online:
October 06 2009
Citation
Julia Esser, Marija Rakonjac, Bettina Hofmann, Lutz Fischer, Patrick Provost, Gisbert Schneider, Dieter Steinhilber, Bengt Samuelsson, Olof Rådmark; Coactosin-like protein functions as a stabilizing chaperone for 5-lipoxygenase: role of tryptophan 102. Biochem J 1 January 2010; 425 (1): 265–274. doi: https://doi.org/10.1042/BJ20090856
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.